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Background
The step between pyruvate production by glycolysis in the
cytosol and movement into the mitochondrial matrix has
largely been unstudied due to the lack of identity of the
genes that mediate this process. The discovery of the
Mitochondrial Pyruvate Carrier (MPC) opens this over-
looked aspect of metabolism to interrogation. The dispen-
sation of pyruvate represents an important and highly
regulated decision within the cell. This is especially true in
rapidly proliferating cells including those found in tumors.
Given the reliance of cancer cells on glycolysis and the
concomitant suppression of mitochondrial metabolism we
hypothesize that modulation of the MPC may serve to
promote and reinforce the Warburg Effect.
Materials and methods
Publicly available datasets were queried for differential
expression of MPC1 and MPC2 (TGCA and GEO). An
array of cell lines representing various cancers were stably
infected with MPC1 and MPC2 or empty vector and
assayed for growth differences in 2D as well as 3D (soft
agar and spheroid formation).
Results
MPC1 and MPC2 transcript levels are significantly
reduced in multiple cancers compared to the adjacent
normal tissue including forms of gastric, colon, breast,
ovarian, and renal cancers. These expression changes
have been confirmed using qPCR and immunoblotting.
In addition to altered expression, low MPC correlates
with decreased survival across multiple cancer types. We
reasoned that cancer cells would reduce MPC expression
to promote the Warburg Effect to fuel rapid growth and
relied on in vitro cell culture to manipulate MPC expres-
sion. The re-expression of MPC1 and MPC2 results in
no change in cell viability or apoptosis but causes
reduced attachment in culture plates as well as reduced
growth in soft agar and spheroids. In addition to the in
vitro studies, xenograft models have recapitulated these
growth differences. We have confirmed MPC expression
produces alterations in metabolism including increased
oxygen consumption with pyruvate as a substrate,
a reduction in lactate production, and an increase in
mitochondrial membrane potential.
Conclusions
MPC expression is reduced in many types of cancer and
its re-expression results in changes in metabolism and
growth as measured by multiple assays. As expected, MPC
expression facilitates pyruvate movement into the mito-
chondria and reduces the Warburg Effect. We are now
investigating the effect of MPC expression on different cell
subpopulations as well as the root cause of the expression
changes observed in cancer.
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